ANG Lifesciences India Ltd - 540694 - Board Meeting Outcome for Outcome Of Board Meeting
With reference to the cited subject matter, we would like to inform you that the Board of Directors of the Company at its meeting held on today i.e., 14th August, 2023, have inter- alia, transacted the following item(s) of the Agenda as mentioned in the attachment ANG Lifesciences India Ltd - 540694 - Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015.
ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015 ('LODR'), we hereby inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on August 14th, 2023 at 4:30 PM at the Registered Office of the Company as mentioned in the attachment ANG Lifesciences India Ltd - 540694 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please enclosed the confirmation certifiacte as received from RTA - Bigshare Services Pvt Ltd as per Regulation 74(5) of the SEBI (Depository and Participant) Regulations, 2018 for the quarter ended as at 30.06.2023 ANG Lifesciences India Ltd - 540694 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Please find enclosed the Annual Secretarial Compliance report for the year ended as at 31st march, 2023 ANG Lifesciences India Ltd - 540694 - Closure of Trading Window
The trading window for dealing in the securities of the company shall remain closed from 01st July, 2023 for the insider, designated persons of the company and their immediate relatives till the end of 48 hrs. after the declaration of Unaudited Standalone and Consolidated Financial Result of the company for the quarter ended on 30th june 2023. ANG Lifesciences India Ltd - 540694 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 & 47 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find enclosed herewith copies of Newspaper Advertisement of the Consolidated & Standalone Audited Financial Results for the Quarter & Financial year ended 31st March, 2023, published in the English Newspaper having nationwide circulation -Business Standard and one in Vernacular Newspaper - Desh Sewak on Thursday, 1*-June-2023. ANG Lifesciences India Ltd - 540694 - Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Pursuant to Regulation 40(9) of the Securities and Exchange of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the certificate Issued by Practicing Company Secretary for the year ended 31st March, 2023. ANG Lifesciences India Ltd - 540694 - Statement On Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations)
Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019, we hereby confirm that there is no deviation or variation in use of proceeds raised through preferential issue of equity shares thereunder. A statement of deviation, duly reviewed by Audit Committee is attached herewith as Annexure A.
